Sort
51,593 grants matching “hepatitis”
Chicago Clinical Trials Unit
$2,093,731Babafemi O Taiwo · Northwestern University At Chicago · UM1 · FY2019 · AI
Integrated heart-liver-vascular systems for drug testing in human health and dise
$2,092,852Gordana Vunjak-Novakovic · Columbia University Health Sciences · UH3 · FY2015 · EB
Integrated heart-liver-vascular systems for drug testing in human health and dise
$2,092,321Gordana Vunjak-Novakovic · Columbia Univ New York Morningside · UH3 · FY2014 · EB
Task D01 Woodchuck Animal Model for Testing Hepatitis B Virus (HBV) Therapeutics
$2,090,969Paul Cote · Georgetown University · N01 · FY2011 · AI
Control of Autoimmunity by Regulatory T Cells
$2,090,044Ethan M. Shevach · Niaid Extramural Activities · Z01 · FY2007 · AI
Molecular Genetics Of Heritable Human Disorders
$2,089,701Janice Chou · Child Health And Human Development · Z01 · FY2007 · HD
NORTHWESTERN ADULT AIDS CLINICAL TRIALS UNIT
$2,088,641Northwestern University · U01 · FY2000 · AI
Integrating innate and adaptive pathways in vaccine responses
$2,088,086Jeffrey Victor Ravetch · Rockefeller University · U19 · FY2019 · AI
Integrating innate and adaptive pathways in vaccine responses
$2,087,906Jeffrey Victor Ravetch · Rockefeller University · U19 · FY2020 · AI
CLINICAL AND LABORATORY STUDIES OF MALIGNANT LYMPHOMAS
$2,087,820Stanford University · P01 · FY2002 · CA
Integrating innate and adaptive pathways in vaccine responses
$2,087,668Jeffrey Victor Ravetch · Rockefeller University · U19 · FY2021 · AI
Integrating innate and adaptive pathways in vaccine responses
$2,087,498Jeffrey Victor Ravetch · Rockefeller University · U19 · FY2022 · AI
Integrating innate and adaptive pathways in vaccine responses
$2,087,423Jeffrey Victor Ravetch · Rockefeller University · U19 · FY2023 · AI
ADULT THERAPEUTIC CLINICAL TRIALS PROGRAM FOR AIDS
$2,086,388University Of North Carolina Chapel Hill · U01 · FY2003 · AI
ADULT THERAPEUTIC CLINICAL TRIALS PROGRAM FOR AIDS
$2,083,770University Of North Carolina Chapel Hill · U01 · FY2004 · AI
Broadly Effective HCV Vaccine
$2,083,528Mansun Law · Scripps Research Institute, The · P01 · FY2023 · AI
Broadly Effective HCV Vaccine
$2,083,528Mansun Law · Scripps Research Institute, The · P01 · FY2024 · AI
Johns Hopkins University Baltimore India Clinical Trail Unit (JHUBI CTU)
$2,082,659Amita Gupta · Johns Hopkins University · UM1 · FY2022 · AI
Molecular Regulation Of RNA Metabolism
$2,082,498Richard J Maraia · Eunice Kennedy Shriver National Institute Of Child Health & Human Development · ZIA · FY2021 · HD
(HVTN) HIV VACCINE TRIAL UNITS
$2,081,637Johns Hopkins University · U01 · FY2003 · AI
New Approaches To Active Immunoprophylaxis
$2,080,655Robert H. Purcell · Niaid Extramural Activities · Z01 · FY2007 · AI
Causal Inference Methods for HIV Prevention Studies Among Networks of People Who Use Drugs
$2,080,476Ashley Lynn Buchanan · University Of Rhode Island · DP2 · FY2018 · DA
A Cardiovascular-NASH disease nexus: Common Mechanisms and Treatments?
$2,078,938Christopher K Glass · University Of California, San Diego · P01 · FY2024 · HL
Molecular Biology and Genetics of Human Tumor Viruses
$2,078,646Paul F Lambert · University Of Wisconsin-Madison · P01 · FY2015 · CA
SAN DIEGO AIDS CLINICAL TRIAL UNIT
$2,078,195University Of California San Diego · U01 · FY2003 · AI